3624 results for «2568»
3624 results
Imaging in LAA occlusion: from planning to final assessment
19 May 2022 – From EuroPCR 2022
Consult this session to learn about imaging supporting LAA occlusion procedure, how to combine different imaging techniques to guide this intervention and their value for procedure planning.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation
19 May 2022 – From EuroPCR 2022
In this session from EuroPCR 2022, the speakers introduce different options available for treating tricuspid regurgitation. They discuss the anatomical considerations that define suitable candidates and review different transcatheter options and their key differentiators.
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...
2022: a tipping point in the treatment of mitral regurgitation patients
17 May 2022 – From EuroPCR 2022
With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
Robotic-assisted intervention: latest clinical insights and applications for complex PCI
18 May 2022 – From EuroPCR 2022
How does robotic assistance work in practice in the cathlab? This is the main question this EuroPCR 2022 session aims to answer. Watch it if you wish to understand the functions and capabilities of the Corpath GRX system, learn from a recorded case about best procedural practices and workflow...
Stent failure: how to treat, how to prevent
18 May 2022 – From EuroPCR 2022
With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...
Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release
18 May 2022 – From EuroPCR 2022
Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.
The right valve choice for TAVI patient longevity and durability
18 May 2022 – From EuroPCR 2022
Watch this session to learn about the impact of age and life expectancy on decision-making for TAVI, to become aware of the durability data of the current TAVI platform, and to revise contemporary implantation techniques and procedural goals for future TAVI-in-TAVI.
The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms
18 May 2022 – From EuroPCR 2022
Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
Transradial approach, from complex PCI to peripheral intervention
19 May 2022 – From EUROPCR 2022
Watch this session if you want to demonstrate how to optimise challenging coronary and peripheral cases using dedicated devices in transradial approach, to appreciate the value of transradial approach for complex PCI and carotid artery stenting and to acknowledge Ultimaster DES results in high bleeding risk patient...
Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for
18 May 2022 – From EuroPCR 2022
Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...
